IHME logo
Loading...

Simon Hay

Professor; Director of Research Strategy

Highly Cited Researcher 2022, ClarivateSimon I. Hay, DPhil, DSc, FMedSci is a Professor in the Department of Health Metrics Sciences in the School of Medicine at the University of Washington, and Director of Research Strategy at the Institute for Health Metrics and Evaluation (IHME). His career has focused on spatial and temporal aspects of infectious disease epidemiology to support the more rational implementation of disease control.

As Director of Research Strategy, Prof. Hay leads the strategic planning for research across IHME, primarily through developing an integrated portfolio of work that best presents the continued innovation and results of the Institute’s annually produced global public goods. He guides IHME’s geospatial research, leading work to identify common problems, solutions, and innovations in local disease burden and small area estimation. He also fosters strategic partnerships with inter-governmental organizations, government agencies, and other key user groups.

Prof. Hay obtained his doctorates from the University of Oxford, where he remains a member of congregation. He has published >650 peer-reviewed and other contributions, including two research monographs; these are cited collectively >60,000 times each year, leading to an h-index of >220 and >365,000 lifetime citations. He was named a highly cited researcher by the Clarivate Web of Science Group from 2018 to 2023 inclusive. Please see ORCID and Research Gate for more details.

Prof. Hay was awarded the Scientific Medal (2008) of the Zoological Society of London and the Back Award (2012) of the Royal Geographical Society for research contributing to public health policy. He has also been awarded the Bailey K. Ashford Medal (2013) of the American Society of Tropical Medicine and Hygiene (ASTMH) and the Chalmers Memorial Medal (2015) of the Royal Society of Tropical Medicine and Hygiene (RSTMH), both for exceptional contributions to tropical medicine. Recently, Prof. Hay received the “10 to End” innovator prize from Malaria No More (2019). The prize is presented for innovation helping to make the end of malaria possible in our lifetimes.

Prof. Hay has been elected to the Board of Trustees of the RSTMH and served as its 52nd President (2013–2015). He has also been elected to the fellowship of the American Society of Tropical Medicine and Hygiene (FASTMH), the Royal College of Physicians of Edinburgh (FRCP Edin), the Academy of Medical Sciences (FMedSci), and the American Association for the Advancement of Science (AAAS).

Publications

Showing 1 - 5 of 339 results
GBD 2021 Pulmonary Arterial Hypertension Collaborators. Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine. 18 October 2024. doi: 10.1016/S2213-2600(24)00295-9.
GBD 2021 Tobacco Forecasting Collaborators. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health. 2 October 2024. doi: 10.1016/S2468-2667(24)00166-X
Naghavi M, Vollset SE, Ikuta K, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet. 16 September 2024. doi: 10.1016/S0140-6736(24)01867-1.
Sirota, SB, Doxey, MC, Dominguez, R-MV, et al. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: results from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. 9 September 2024. doi: 10.1016/S1473-3099(24)00430-4.
GBD US Health Disparities Collaborators. Mortality due to falls by county, age group, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities. The Lancet Public Health. 29 July 2024. doi: 10.1016/S2468-2667(24)00122-1.